Tezepelumab: all 47 studies that test it

Page 1 of 1. Open to participants first (13), then studies with results posted, then the rest; newest registration first within each.

• Efficacy of an Anti-TSLP Monoclonal Antibody in the Management of Chronic Bronchial Disease Induced by Bronchiolitis Obliterans Syndrome in Allogeneic Hematopoietic Stem Cells Transplantation RecipientsRecruitingNCT07771855Phase 2
• Real-World Effectiveness of Tezepelumab in Allergic Bronchopulmonary AspergillosisNot yet recruitingNCT07757841Not applicable
• A Study to Investigate NPS and Symptoms in Chinese Adult Participants With CRSwNP Initiating Treatment With TezepelumabRecruitingNCT07520162Phase 3
• Phase 3b Study in Patients With Severe Asthma Treated With TezepelumabRecruitingNCT07363642Phase 3
• Compare the Efficacy and Safety of QL2302 Versus Tezspire® in Severe AsthmaNot yet recruitingNCT07302516Phase 3
• Effect of Tezepelumab on Barrier Function in Severe Asthmatic Patients With and Without Comorbid Chronic Rhinosinusitis With Nasal PolypsNot yet recruitingNCT07046117Not applicable
• Efficacy of Tezepelumab in Peanut Oral ImmunotherapyRecruitingNCT07015996Phase 2
• A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)RecruitingNCT06883305Phase 3
• A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)RecruitingNCT06878261Phase 3
• Opening the "Black Box" on Tezepelumab's Effect on Chronic Rhinosinusitis With Severe AsthmaNot yet recruitingNCT06740045Phase 3
• Tezepelumab in the Treatment of Emergency Room Asthma in Adults (TERAA)RecruitingNCT06705764Phase 4
• A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe AsthmaRecruitingNCT06023589Phase 3
• Effects of Blocking TSLP on Airway Inflammation and the Epithelial Immune-response to Exacerbation Triggers in Patients With COPDRecruitingNCT05507242Phase 2
• Tezepelumab Efficacy and Safety in Reducing Oral Corticosteroid Use in Adults With Oral Corticosteroid Dependent AsthmaTerminatedNCT05398263Phase 3Results posted
• Effectiveness and Safety Study of Tezepelumab in Adults & Adolescent Participants With Severe Asthma in the United StatesCompletedNCT05329194Phase 4Results posted
• Study to Evaluate Efficacy and Safety of Tezepelumab in Reducing Oral Corticosteroid Use in Adult Patients With Severe AsthmaCompletedNCT05274815Phase 3Results posted
• Study to Assess the Effect of Tezepelumab on the Immune Response to Influenza Vaccination in Participants With AsthmaCompletedNCT05062759Phase 3Results posted
• Efficacy and Safety of Tezepelumab in Participants With Severe Chronic Rhinosinusitis With Nasal PolyposisCompletedNCT04851964Phase 3Results posted
• Study to Evaluate Tezepelumab in Adults With Chronic Spontaneous UrticariaCompletedNCT04833855Phase 2Results posted
• Study to Evaluate the Pharmacokinetics of Tezepelumab in Children With AsthmaCompletedNCT04673630Phase 1Results posted
• Long-term Safety of Tezepelumab in Japanese Subjects With Inadequately Controlled Severe AsthmaCompletedNCT04048343Phase 3Results posted
• Tezepelumab COPD Exacerbation StudyCompletedNCT04039113Phase 2Results posted
• Tezepelumab Home Use StudyCompletedNCT03968978Phase 3Results posted
• Study to Evaluate Tezepelumab in Adults With Severe Uncontrolled AsthmaCompletedNCT03927157Phase 3Results posted
• A Dose Ranging Placebo-Controlled Double-Blind Study to Evaluate the Safety and Efficacy of Tezepelumab in Atopic DermatitisTerminatedNCT03809663Phase 2Results posted
• Extension Study to Evaluate the Safety and Tolerability of Tezepelumab in Adults and Adolescents With Severe, Uncontrolled AsthmaCompletedNCT03706079Phase 3Results posted
• Study to Evaluate Tezepelumab on Airway Inflammation in Adults With Uncontrolled Asthma (CASCADE)CompletedNCT03688074Phase 2Results posted
• Study to Evaluate the Efficacy and Safety of Tezepelumab in Reducing Oral Corticosteroid Use in Adults With Oral Corticosteroid Dependent AsthmaCompletedNCT03406078Phase 3Results posted
• Study to Evaluate Tezepelumab in Adults & Adolescents With Severe Uncontrolled AsthmaCompletedNCT03347279Phase 3Results posted
• Phase 2a Study to Evaluate the Efficacy and Safety of MEDI9929 in Adults With Atopic DermatitisCompletedNCT02525094Phase 2Results posted
• A Study to Evaluate the Pharmacokinetics of MEDI9929 (AMG 157) in Adolescents With Mild to Moderate AsthmaCompletedNCT02512900Phase 1Results posted
• Anti-TSLP (AMG 157) Plus Antigen-Specific Immunotherapy for Induction of Tolerance in Individuals With Cat AllergyCompletedNCT02237196Phase 1/2Results posted
• Study to Evaluate the Efficacy and Safety of MEDI9929 (AMG 157) in Adult Subjects With Inadequately Controlled, Severe AsthmaCompletedNCT02054130Phase 2Results posted
• Double-blind, Multiple Dose Study of Tezepelumab (AMG 157) in Adults With Mild Atopic AsthmaCompletedNCT01405963Phase 1Results posted
• Safety Study of Tezepelumab (AMG 157) in Healthy AdultsCompletedNCT00972179Phase 1Results posted
• Safety Study of Tezepelumab (AMG 157) in Healthy Adults and Adults With Atopic DermatitisCompletedNCT00757042Phase 1Results posted
• A Study to Investigate Changes in Symptoms in Adult Participants With Chronic Rhinosinusitis With Nasal Polyposis Initiating Treatment With TezepelumabActive, not recruitingNCT06706817Phase 3
• Explore the Efficacy and Mechanism of Action of Tezepelumab in Eosinophilic Granulomatosis With PolyangiitisActive, not recruitingNCT06230354Phase 2
• Tezepelumab in Allergic Rhinitis and Asthma Study (TEZARS)Active, not recruitingNCT06189742Phase 2
• Tezepelumab and Methacholine Airway Hyperresponsiveness in Participants With Mild Allergic AsthmaStatus unknownNCT05740748Phase 2
• REVErsing Airway Remodelling With TezepelumabCompletedNCT05651841Phase 3
• Efficacy and Safety of Tezepelumab in Patients With Eosinophilic EsophagitisActive, not recruitingNCT05583227Phase 3
• Tezepelumab on Airway Structure and Function in Patients With Uncontrolled Moderate-to-severe AsthmaCompletedNCT05280418Phase 3
• Tezepelumab Phase 1 PK Study in Healthy Chinese SubjectsCompletedNCT04362410Phase 1
• A Study to Evaluate the Pharmacokinetics of Tezepelumab After Being Delivered by an Accessorized Pre Filled Syringe or Autoinjector Compared With Vial and Syringe in Healthy Adult SubjectsCompletedNCT03989544Phase 1
• Effects of Anti-TSLP in Patients With AsthmaCompletedNCT02698501Phase 2
• A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of MEDI9929 After Single Administration in Healthy Male Japanese SubjectsCompletedNCT01913028Phase 1

← Tezepelumab overview